C

Co-Diagnostics
D

CODX

0.73000
USD
0.00
(0.45%)
مغلق
حجم التداول
1,213
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
23,308,719
أصول ذات صلة
    A
    APT
    0.13000
    (2.49%)
    5.35000 USD
    A
    AYTU
    -0.03000
    (-2.16%)
    1.36000 USD
    B
    BIOC
    -0.09610
    (-18.27%)
    0.42990 USD
    C
    CEMI
    0.02200
    (6.47%)
    0.35000 USD
    N
    NVAX
    0.05000
    (0.58%)
    8.72000 USD
    O
    OPK
    -0.03000
    (-1.91%)
    1.54000 USD
    Q
    QDEL
    1.860
    (4.32%)
    44.890 USD
    T
    TTOO
    0.01800
    (5.44%)
    0.34900 USD
    V
    VXRT
    0.00480
    (0.79%)
    0.61260 USD
    المزيد
الأخبار

العنوان: Co/Diagnostics

القطاع: Healthcare
الصناعة: Medical Devices
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detectionand/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.